CVS Health Corporation $CVS Position Lessened by Amundi

Amundi cut its stake in CVS Health Corporation (NYSE:CVS) by 19.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,816,037 shares of the pharmacy operator’s stock after selling 948,300 shares during the period. Amundi owned 0.30% of CVS Health worth $254,775,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Norges Bank acquired a new stake in shares of CVS Health in the 2nd quarter worth about $1,358,698,000. Dodge & Cox grew its position in CVS Health by 4.8% in the 1st quarter. Dodge & Cox now owns 73,459,122 shares of the pharmacy operator’s stock worth $4,976,856,000 after purchasing an additional 3,353,223 shares during the last quarter. Invesco Ltd. increased its stake in shares of CVS Health by 15.3% in the second quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock valued at $1,623,270,000 after purchasing an additional 3,118,626 shares during the period. Nuveen LLC bought a new stake in shares of CVS Health during the first quarter valued at approximately $204,421,000. Finally, Robeco Institutional Asset Management B.V. boosted its position in shares of CVS Health by 815.2% during the second quarter. Robeco Institutional Asset Management B.V. now owns 2,663,111 shares of the pharmacy operator’s stock worth $183,701,000 after buying an additional 2,372,121 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on CVS. Argus boosted their price target on CVS Health from $80.00 to $91.00 and gave the stock a “buy” rating in a research report on Tuesday, November 4th. UBS Group reaffirmed a “buy” rating on shares of CVS Health in a report on Wednesday. Leerink Partners raised their target price on shares of CVS Health from $86.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, October 16th. Baird R W raised shares of CVS Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 14th. Finally, Robert W. Baird upgraded shares of CVS Health from a “neutral” rating to an “outperform” rating and raised their price objective for the company from $71.00 to $82.00 in a research note on Thursday, August 14th. Two research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $90.95.

CVS Health Stock Down 1.6%

CVS stock opened at $75.52 on Friday. The firm has a market cap of $95.87 billion, a PE ratio of 198.74, a P/E/G ratio of 0.74 and a beta of 0.48. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $85.15. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63. The firm has a 50 day simple moving average of $78.75 and a 200 day simple moving average of $71.29.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. During the same quarter in the previous year, the business posted $1.09 earnings per share. The firm’s quarterly revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Equities research analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd were issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.5%. The ex-dividend date of this dividend was Thursday, October 23rd. CVS Health’s dividend payout ratio is currently 700.00%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.